| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortitis | 9 | 2023 | 77 | 3.950 |
Why?
|
| Myocardium | 28 | 2024 | 4765 | 2.970 |
Why?
|
| Amyloidosis | 11 | 2020 | 878 | 2.100 |
Why?
|
| Giant Cell Arteritis | 8 | 2024 | 308 | 2.070 |
Why?
|
| Autopsy | 14 | 2022 | 1011 | 1.990 |
Why?
|
| Temporal Arteries | 5 | 2024 | 155 | 1.650 |
Why?
|
| Myocarditis | 9 | 2024 | 802 | 1.610 |
Why?
|
| Hydrogen Peroxide | 8 | 2008 | 740 | 1.470 |
Why?
|
| Cardiomyopathies | 7 | 2024 | 2060 | 1.340 |
Why?
|
| Aorta | 8 | 2023 | 2040 | 1.330 |
Why?
|
| Tunica Intima | 5 | 2010 | 455 | 1.200 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 6 | 2013 | 17 | 1.150 |
Why?
|
| Immunoglobulin G | 12 | 2023 | 4555 | 1.100 |
Why?
|
| Diagnosis, Differential | 34 | 2021 | 12975 | 1.030 |
Why?
|
| Shock, Cardiogenic | 3 | 2022 | 704 | 0.990 |
Why?
|
| Mesenteric Vascular Occlusion | 3 | 2014 | 93 | 0.990 |
Why?
|
| Death, Sudden | 2 | 2024 | 301 | 0.960 |
Why?
|
| Mesenteric Arteries | 2 | 2014 | 177 | 0.920 |
Why?
|
| Cardiovascular System | 2 | 2022 | 838 | 0.910 |
Why?
|
| Guanine Nucleotide Exchange Factors | 10 | 2013 | 572 | 0.870 |
Why?
|
| Heart Neoplasms | 6 | 2016 | 374 | 0.860 |
Why?
|
| Coronary Aneurysm | 2 | 2018 | 234 | 0.800 |
Why?
|
| Aortic Diseases | 6 | 2023 | 741 | 0.770 |
Why?
|
| Macrophages | 7 | 2024 | 5775 | 0.740 |
Why?
|
| Pheochromocytoma | 2 | 2018 | 326 | 0.730 |
Why?
|
| Immune System Diseases | 3 | 2016 | 253 | 0.720 |
Why?
|
| Syncope | 4 | 2018 | 431 | 0.710 |
Why?
|
| Casein Kinase Ialpha | 3 | 2013 | 26 | 0.710 |
Why?
|
| Prosthesis Failure | 2 | 2020 | 1194 | 0.700 |
Why?
|
| Fatal Outcome | 13 | 2020 | 1836 | 0.680 |
Why?
|
| Exanthema | 3 | 2022 | 503 | 0.680 |
Why?
|
| Anemia, Hemolytic | 1 | 2020 | 164 | 0.660 |
Why?
|
| Hematuria | 1 | 2020 | 232 | 0.650 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2019 | 1529 | 0.630 |
Why?
|
| Coronary Vessels | 8 | 2023 | 3093 | 0.610 |
Why?
|
| Lung | 17 | 2022 | 10060 | 0.610 |
Why?
|
| beta 2-Microglobulin | 1 | 2019 | 330 | 0.600 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2012 | 2469 | 0.590 |
Why?
|
| Pathology, Surgical | 3 | 2016 | 146 | 0.580 |
Why?
|
| Amyloid | 3 | 2017 | 848 | 0.580 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2017 | 29 | 0.570 |
Why?
|
| Aorta, Thoracic | 6 | 2023 | 1109 | 0.560 |
Why?
|
| Aneurysm, False | 2 | 2017 | 264 | 0.560 |
Why?
|
| Heart Transplantation | 10 | 2019 | 3301 | 0.560 |
Why?
|
| Tongue | 2 | 2011 | 406 | 0.560 |
Why?
|
| Echocardiography | 15 | 2021 | 5033 | 0.550 |
Why?
|
| Atrial Appendage | 2 | 2021 | 284 | 0.540 |
Why?
|
| Lipomatosis | 1 | 2017 | 112 | 0.540 |
Why?
|
| Humans | 167 | 2024 | 766000 | 0.540 |
Why?
|
| Plasma Cells | 4 | 2015 | 597 | 0.540 |
Why?
|
| Arteritis | 2 | 2023 | 160 | 0.540 |
Why?
|
| Iron Overload | 1 | 2019 | 245 | 0.530 |
Why?
|
| Headache | 3 | 2022 | 1259 | 0.530 |
Why?
|
| Coronary Artery Disease | 7 | 2019 | 6540 | 0.530 |
Why?
|
| Aged | 72 | 2024 | 171161 | 0.530 |
Why?
|
| Amyloid Neuropathies, Familial | 2 | 2016 | 181 | 0.520 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2018 | 125 | 0.520 |
Why?
|
| Heart Diseases | 10 | 2022 | 2817 | 0.510 |
Why?
|
| Mammary Arteries | 2 | 2007 | 81 | 0.510 |
Why?
|
| Male | 109 | 2024 | 363855 | 0.500 |
Why?
|
| Heart | 8 | 2024 | 4416 | 0.500 |
Why?
|
| Bacterial Infections | 2 | 2015 | 1387 | 0.500 |
Why?
|
| Saphenous Vein | 1 | 2018 | 519 | 0.490 |
Why?
|
| Adrenal Glands | 1 | 2018 | 556 | 0.490 |
Why?
|
| Pulmonary Artery | 3 | 2021 | 1938 | 0.490 |
Why?
|
| Heart Septum | 1 | 2016 | 303 | 0.490 |
Why?
|
| Popliteal Artery | 1 | 2017 | 311 | 0.480 |
Why?
|
| Middle Aged | 73 | 2024 | 223025 | 0.480 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2017 | 144 | 0.480 |
Why?
|
| Endocardium | 3 | 2020 | 249 | 0.480 |
Why?
|
| Splenectomy | 1 | 2016 | 389 | 0.470 |
Why?
|
| Aneurysm | 1 | 2018 | 343 | 0.470 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2015 | 171 | 0.470 |
Why?
|
| Dyspnea | 8 | 2019 | 1351 | 0.470 |
Why?
|
| Takayasu Arteritis | 2 | 2013 | 105 | 0.460 |
Why?
|
| Extracellular Fluid | 1 | 2015 | 165 | 0.460 |
Why?
|
| Hyperplasia | 5 | 2013 | 1142 | 0.450 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2018 | 731 | 0.450 |
Why?
|
| Endovascular Procedures | 4 | 2015 | 2215 | 0.440 |
Why?
|
| Cytochrome b Group | 1 | 2013 | 59 | 0.440 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 574 | 0.440 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 281 | 0.430 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 2136 | 0.430 |
Why?
|
| Autoimmune Diseases | 5 | 2012 | 2249 | 0.420 |
Why?
|
| Mitral Valve | 2 | 2020 | 1474 | 0.420 |
Why?
|
| Endocarditis, Bacterial | 2 | 2014 | 434 | 0.420 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 96 | 0.420 |
Why?
|
| Biopsy | 9 | 2024 | 6768 | 0.410 |
Why?
|
| Carotid Artery, Common | 1 | 2013 | 172 | 0.410 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2016 | 1337 | 0.400 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2013 | 175 | 0.400 |
Why?
|
| Endothelium, Vascular | 6 | 2010 | 4423 | 0.400 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2012 | 52 | 0.400 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 1313 | 0.390 |
Why?
|
| Amyloidosis, Familial | 1 | 2012 | 16 | 0.390 |
Why?
|
| Vasculitis | 3 | 2023 | 528 | 0.390 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 1464 | 0.390 |
Why?
|
| Vascular Diseases | 3 | 2022 | 1161 | 0.390 |
Why?
|
| Nervous System Diseases | 1 | 2022 | 1657 | 0.390 |
Why?
|
| Pulmonary Embolism | 5 | 2021 | 2596 | 0.380 |
Why?
|
| Female | 85 | 2024 | 396158 | 0.380 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 1494 | 0.380 |
Why?
|
| Systemic Vasculitis | 1 | 2012 | 37 | 0.380 |
Why?
|
| Aortic Valve | 3 | 2020 | 1964 | 0.370 |
Why?
|
| Surgical Procedures, Operative | 1 | 2022 | 1931 | 0.360 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 483 | 0.360 |
Why?
|
| Electrocardiography | 7 | 2021 | 6408 | 0.360 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2011 | 42 | 0.360 |
Why?
|
| Sarcoidosis | 1 | 2016 | 535 | 0.360 |
Why?
|
| Histological Techniques | 1 | 2011 | 193 | 0.350 |
Why?
|
| Renal Dialysis | 2 | 2019 | 1791 | 0.340 |
Why?
|
| Iron | 1 | 2019 | 1810 | 0.340 |
Why?
|
| Coronary Artery Bypass | 3 | 2018 | 2188 | 0.340 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 15639 | 0.340 |
Why?
|
| Edema | 4 | 2016 | 763 | 0.340 |
Why?
|
| Diffuse Axonal Injury | 2 | 2009 | 49 | 0.340 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 800 | 0.330 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 4112 | 0.330 |
Why?
|
| Prealbumin | 1 | 2012 | 261 | 0.330 |
Why?
|
| Body Height | 1 | 2016 | 1561 | 0.330 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1127 | 0.330 |
Why?
|
| Myxoma | 2 | 2007 | 114 | 0.320 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2013 | 545 | 0.310 |
Why?
|
| Axons | 5 | 2004 | 1677 | 0.310 |
Why?
|
| Aortic Rupture | 1 | 2012 | 322 | 0.310 |
Why?
|
| Traumatology | 1 | 2009 | 101 | 0.310 |
Why?
|
| Aged, 80 and over | 25 | 2021 | 59493 | 0.310 |
Why?
|
| Immunohistochemistry | 12 | 2021 | 11035 | 0.300 |
Why?
|
| Chest Pain | 5 | 2019 | 1101 | 0.300 |
Why?
|
| Atherosclerosis | 4 | 2015 | 3417 | 0.300 |
Why?
|
| Carotid Artery, Internal | 2 | 2008 | 440 | 0.300 |
Why?
|
| Mediastinal Diseases | 1 | 2008 | 91 | 0.290 |
Why?
|
| Pleural Effusion | 2 | 2015 | 344 | 0.290 |
Why?
|
| Venous Thromboembolism | 2 | 2018 | 1883 | 0.290 |
Why?
|
| Polyvinyls | 1 | 2008 | 153 | 0.290 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2008 | 250 | 0.290 |
Why?
|
| Calcinosis | 1 | 2016 | 1475 | 0.290 |
Why?
|
| Puerperal Disorders | 1 | 2010 | 304 | 0.290 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10431 | 0.290 |
Why?
|
| Pericardium | 3 | 2020 | 679 | 0.280 |
Why?
|
| Casein Kinase I | 1 | 2007 | 46 | 0.280 |
Why?
|
| Brain Injuries | 6 | 2004 | 2062 | 0.280 |
Why?
|
| Stents | 5 | 2015 | 3191 | 0.280 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2006 | 48 | 0.270 |
Why?
|
| Embolism | 2 | 2007 | 401 | 0.270 |
Why?
|
| Dura Mater | 1 | 2008 | 292 | 0.270 |
Why?
|
| Radiography | 8 | 2016 | 6943 | 0.270 |
Why?
|
| Immunosuppressive Agents | 3 | 2021 | 4213 | 0.270 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2417 | 0.270 |
Why?
|
| Predictive Value of Tests | 8 | 2024 | 15401 | 0.270 |
Why?
|
| Hemosiderosis | 1 | 2007 | 66 | 0.270 |
Why?
|
| Foreign Bodies | 1 | 2011 | 402 | 0.270 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 503 | 0.260 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2008 | 297 | 0.260 |
Why?
|
| Heart Atria | 2 | 2011 | 1363 | 0.260 |
Why?
|
| Carotid Artery Diseases | 2 | 2014 | 872 | 0.260 |
Why?
|
| Forensic Pathology | 2 | 2016 | 23 | 0.260 |
Why?
|
| Carotid Arteries | 2 | 2014 | 932 | 0.260 |
Why?
|
| Specimen Handling | 1 | 2011 | 704 | 0.260 |
Why?
|
| Models, Organizational | 1 | 2009 | 548 | 0.260 |
Why?
|
| Papillary Muscles | 1 | 2006 | 192 | 0.260 |
Why?
|
| Behavior Therapy | 1 | 2012 | 886 | 0.250 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2012 | 1249 | 0.250 |
Why?
|
| Radiography, Thoracic | 4 | 2020 | 1319 | 0.250 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3314 | 0.250 |
Why?
|
| Biomedical Research | 1 | 2021 | 3458 | 0.250 |
Why?
|
| Myocardial Infarction | 7 | 2017 | 11506 | 0.250 |
Why?
|
| Phloroglucinol | 1 | 2005 | 6 | 0.250 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2005 | 32 | 0.240 |
Why?
|
| Body Weight | 1 | 2016 | 4626 | 0.240 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2018 | 1092 | 0.240 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2006 | 154 | 0.240 |
Why?
|
| Adult | 50 | 2024 | 223106 | 0.240 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 1393 | 0.240 |
Why?
|
| Retinal Vasculitis | 1 | 2005 | 46 | 0.240 |
Why?
|
| Conducted Energy Weapon Injuries | 2 | 2014 | 2 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2023 | 36545 | 0.240 |
Why?
|
| Immunologic Factors | 2 | 2016 | 1592 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2019 | 20698 | 0.230 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2010 | 530 | 0.230 |
Why?
|
| Brain Stem | 1 | 2009 | 852 | 0.230 |
Why?
|
| Ulnar Artery | 1 | 2004 | 15 | 0.230 |
Why?
|
| Skin | 3 | 2014 | 4482 | 0.230 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 6361 | 0.220 |
Why?
|
| Axonal Transport | 1 | 2004 | 178 | 0.220 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 10260 | 0.220 |
Why?
|
| Blood Chemical Analysis | 2 | 2020 | 434 | 0.220 |
Why?
|
| Cholangiocarcinoma | 2 | 2022 | 577 | 0.220 |
Why?
|
| Bile Duct Neoplasms | 2 | 2022 | 624 | 0.220 |
Why?
|
| Lung Neoplasms | 6 | 2020 | 13482 | 0.220 |
Why?
|
| Disease Progression | 8 | 2024 | 13613 | 0.220 |
Why?
|
| Urinalysis | 2 | 2020 | 369 | 0.220 |
Why?
|
| Societies, Medical | 4 | 2019 | 3955 | 0.220 |
Why?
|
| Radiotherapy | 1 | 2010 | 1491 | 0.220 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2008 | 956 | 0.220 |
Why?
|
| Confusion | 2 | 2017 | 278 | 0.210 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 2144 | 0.210 |
Why?
|
| Troponin I | 3 | 2024 | 656 | 0.210 |
Why?
|
| Head Injuries, Closed | 2 | 2003 | 133 | 0.210 |
Why?
|
| Fever | 5 | 2014 | 1607 | 0.210 |
Why?
|
| Recurrence | 4 | 2018 | 8494 | 0.210 |
Why?
|
| ras Proteins | 2 | 2005 | 1054 | 0.210 |
Why?
|
| B-Lymphocytes | 7 | 2024 | 4783 | 0.210 |
Why?
|
| Inflammation | 7 | 2024 | 10857 | 0.210 |
Why?
|
| Radiation Injuries | 1 | 2010 | 1181 | 0.210 |
Why?
|
| Myocardial Ischemia | 3 | 2014 | 2130 | 0.210 |
Why?
|
| Radiography, Interventional | 3 | 2014 | 1128 | 0.200 |
Why?
|
| Organelles | 1 | 2004 | 263 | 0.200 |
Why?
|
| Hodgkin Disease | 1 | 2010 | 1383 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3111 | 0.200 |
Why?
|
| Serum Albumin | 2 | 2016 | 674 | 0.200 |
Why?
|
| Cause of Death | 2 | 2024 | 3712 | 0.200 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 132 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3233 | 0.200 |
Why?
|
| Chronic Disease | 8 | 2021 | 9351 | 0.200 |
Why?
|
| Endothelial Cells | 4 | 2021 | 3586 | 0.200 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2004 | 152 | 0.200 |
Why?
|
| Proteoglycans | 1 | 2005 | 794 | 0.200 |
Why?
|
| Blood | 1 | 2024 | 597 | 0.200 |
Why?
|
| Serum Amyloid A Protein | 2 | 2015 | 127 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 592 | 0.190 |
Why?
|
| Angioplasty, Balloon | 4 | 2014 | 591 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2005 | 1241 | 0.190 |
Why?
|
| Graft Rejection | 7 | 2015 | 4504 | 0.190 |
Why?
|
| Amino Acid Sequence | 13 | 2017 | 13400 | 0.190 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2004 | 1117 | 0.190 |
Why?
|
| Animals | 58 | 2024 | 168775 | 0.190 |
Why?
|
| Ventricular Fibrillation | 2 | 2014 | 538 | 0.190 |
Why?
|
| Prednisone | 3 | 2012 | 1566 | 0.190 |
Why?
|
| Kidney | 5 | 2021 | 7070 | 0.190 |
Why?
|
| Respiratory Insufficiency | 2 | 2007 | 1241 | 0.180 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2013 | 227 | 0.180 |
Why?
|
| Models, Neurological | 1 | 2009 | 1746 | 0.180 |
Why?
|
| Glucocorticoids | 4 | 2012 | 2156 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2626 | 0.180 |
Why?
|
| Trigeminal Ganglion | 1 | 2022 | 186 | 0.180 |
Why?
|
| Antibody Formation | 1 | 2005 | 1392 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 833 | 0.180 |
Why?
|
| Hand Injuries | 1 | 2004 | 239 | 0.180 |
Why?
|
| Treatment Outcome | 19 | 2024 | 65199 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.180 |
Why?
|
| Computers, Handheld | 2 | 2013 | 211 | 0.180 |
Why?
|
| Mutation | 11 | 2017 | 30208 | 0.180 |
Why?
|
| Caspases | 2 | 2009 | 881 | 0.170 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 3925 | 0.170 |
Why?
|
| Weight Loss | 1 | 2012 | 2711 | 0.170 |
Why?
|
| Heart Failure | 7 | 2019 | 11815 | 0.170 |
Why?
|
| Central Nervous System | 2 | 2009 | 1343 | 0.170 |
Why?
|
| In Situ Hybridization | 2 | 2021 | 1885 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2022 | 220 | 0.170 |
Why?
|
| Lymphocyte Activation | 7 | 2012 | 5503 | 0.170 |
Why?
|
| Heart Ventricles | 3 | 2016 | 3831 | 0.170 |
Why?
|
| Heart Arrest | 3 | 2014 | 1516 | 0.170 |
Why?
|
| Muscle Cells | 1 | 2020 | 194 | 0.170 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 5189 | 0.170 |
Why?
|
| Flavonoids | 1 | 2003 | 446 | 0.160 |
Why?
|
| Lymphocytes | 3 | 2007 | 2602 | 0.160 |
Why?
|
| Neoplasms | 4 | 2024 | 22336 | 0.160 |
Why?
|
| Ribonucleoproteins | 1 | 2002 | 359 | 0.160 |
Why?
|
| Spinal Cord Injuries | 2 | 2006 | 929 | 0.160 |
Why?
|
| Vascular Neoplasms | 1 | 2021 | 167 | 0.160 |
Why?
|
| Renal Artery Obstruction | 2 | 2014 | 216 | 0.160 |
Why?
|
| Risk Factors | 12 | 2024 | 74838 | 0.160 |
Why?
|
| Translocation, Genetic | 2 | 2016 | 1392 | 0.160 |
Why?
|
| Aorta, Abdominal | 2 | 2012 | 626 | 0.160 |
Why?
|
| Molecular Sequence Data | 11 | 2010 | 17597 | 0.160 |
Why?
|
| Mice, Knockout | 16 | 2017 | 14455 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2001 | 463 | 0.150 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 1456 | 0.150 |
Why?
|
| RNA, Viral | 3 | 2022 | 2868 | 0.150 |
Why?
|
| Repressor Proteins | 4 | 2005 | 2974 | 0.150 |
Why?
|
| Marmota | 1 | 2017 | 13 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 280 | 0.150 |
Why?
|
| Paraproteinemias | 2 | 2012 | 251 | 0.150 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2197 | 0.150 |
Why?
|
| Phosphorylation | 7 | 2009 | 8290 | 0.150 |
Why?
|
| Liver | 4 | 2021 | 7558 | 0.150 |
Why?
|
| Subclavian Artery | 2 | 2015 | 138 | 0.150 |
Why?
|
| Camptothecin | 1 | 2021 | 598 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 1604 | 0.140 |
Why?
|
| Transferrin | 1 | 2019 | 283 | 0.140 |
Why?
|
| Giant Cells | 1 | 2018 | 187 | 0.140 |
Why?
|
| Embolization, Therapeutic | 2 | 2017 | 1405 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2020 | 412 | 0.140 |
Why?
|
| Polypharmacy | 1 | 2020 | 307 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2022 | 1820 | 0.140 |
Why?
|
| Hypothermia, Induced | 1 | 2003 | 754 | 0.140 |
Why?
|
| Enbucrilate | 1 | 2017 | 29 | 0.140 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 61 | 0.140 |
Why?
|
| Lung Diseases | 2 | 2008 | 1941 | 0.140 |
Why?
|
| Endarterectomy | 1 | 2018 | 196 | 0.140 |
Why?
|
| Ureteral Diseases | 1 | 2017 | 63 | 0.140 |
Why?
|
| Prosthesis Design | 3 | 2017 | 2111 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 273 | 0.140 |
Why?
|
| Mice | 34 | 2024 | 81821 | 0.140 |
Why?
|
| Ventricular Dysfunction | 1 | 2018 | 143 | 0.140 |
Why?
|
| Coronary Angiography | 4 | 2018 | 4496 | 0.140 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 500 | 0.140 |
Why?
|
| Elastic Tissue | 2 | 2015 | 65 | 0.140 |
Why?
|
| Zinc Fingers | 4 | 2005 | 575 | 0.140 |
Why?
|
| Terminology as Topic | 2 | 2016 | 1536 | 0.140 |
Why?
|
| Cells, Cultured | 7 | 2013 | 18964 | 0.140 |
Why?
|
| Postural Balance | 1 | 2021 | 637 | 0.140 |
Why?
|
| Interferons | 1 | 2020 | 714 | 0.140 |
Why?
|
| Pyridines | 2 | 2013 | 2889 | 0.140 |
Why?
|
| Imidazoles | 1 | 2003 | 1169 | 0.140 |
Why?
|
| Sepsis | 1 | 2011 | 2604 | 0.130 |
Why?
|
| Neuregulin-1 | 2 | 2009 | 140 | 0.130 |
Why?
|
| Critical Care | 1 | 2009 | 2714 | 0.130 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 453 | 0.130 |
Why?
|
| DNA-Binding Proteins | 6 | 2004 | 9600 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 7423 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 352 | 0.130 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 126 | 0.130 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2016 | 54 | 0.130 |
Why?
|
| Stroke Volume | 3 | 2020 | 5590 | 0.130 |
Why?
|
| Epistaxis | 1 | 2017 | 119 | 0.130 |
Why?
|
| Postmortem Changes | 1 | 2016 | 119 | 0.130 |
Why?
|
| Cell Division | 3 | 2003 | 4467 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2009 | 8105 | 0.130 |
Why?
|
| Pathology, Clinical | 2 | 2010 | 374 | 0.130 |
Why?
|
| Angiotensin II | 3 | 2010 | 844 | 0.130 |
Why?
|
| Fatigue | 2 | 2018 | 1552 | 0.130 |
Why?
|
| Ferritins | 1 | 2019 | 600 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 561 | 0.130 |
Why?
|
| Retrospective Studies | 13 | 2021 | 81542 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2016 | 2701 | 0.120 |
Why?
|
| Hypotension, Orthostatic | 1 | 2018 | 258 | 0.120 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2016 | 289 | 0.120 |
Why?
|
| Arthralgia | 2 | 2010 | 459 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 904 | 0.120 |
Why?
|
| Bone Marrow | 3 | 2021 | 2916 | 0.120 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 84 | 0.120 |
Why?
|
| Subcutaneous Tissue | 1 | 2015 | 131 | 0.120 |
Why?
|
| Cardiomegaly | 2 | 2010 | 590 | 0.120 |
Why?
|
| Autoimmunity | 4 | 2013 | 1355 | 0.120 |
Why?
|
| Peroxidases | 2 | 2006 | 134 | 0.120 |
Why?
|
| Guanylate Cyclase | 1 | 1995 | 206 | 0.120 |
Why?
|
| Baltimore | 1 | 2015 | 233 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2006 | 3140 | 0.120 |
Why?
|
| Polyvinyl Alcohol | 1 | 2015 | 74 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 317 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2002 | 1370 | 0.120 |
Why?
|
| Peritoneum | 1 | 2015 | 226 | 0.120 |
Why?
|
| Rats | 12 | 2009 | 23709 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 5 | 2005 | 3750 | 0.110 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2014 | 19 | 0.110 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2014 | 55 | 0.110 |
Why?
|
| Vena Cava Filters | 1 | 2017 | 270 | 0.110 |
Why?
|
| Splanchnic Circulation | 1 | 2014 | 122 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2024 | 1801 | 0.110 |
Why?
|
| Hypertrophy | 2 | 2014 | 562 | 0.110 |
Why?
|
| Pleura | 1 | 2015 | 243 | 0.110 |
Why?
|
| RNA, Messenger | 6 | 2015 | 12772 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 890 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 20135 | 0.110 |
Why?
|
| Lymphocyte Count | 2 | 2016 | 791 | 0.110 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2013 | 45 | 0.110 |
Why?
|
| Bilirubin | 1 | 2015 | 439 | 0.110 |
Why?
|
| Foramen Ovale, Patent | 1 | 2016 | 209 | 0.110 |
Why?
|
| Ascites | 1 | 2015 | 336 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1117 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 22334 | 0.110 |
Why?
|
| Case-Control Studies | 6 | 2024 | 22231 | 0.110 |
Why?
|
| Heme | 1 | 1995 | 316 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2021 | 976 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 536 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2005 | 283 | 0.110 |
Why?
|
| Diverticulum | 1 | 2014 | 137 | 0.110 |
Why?
|
| Flow Cytometry | 5 | 2017 | 5879 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 150 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2012 | 353 | 0.110 |
Why?
|
| Leg | 2 | 2016 | 1088 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 5334 | 0.100 |
Why?
|
| Muscular Diseases | 2 | 2008 | 551 | 0.100 |
Why?
|
| Cryptorchidism | 1 | 2014 | 152 | 0.100 |
Why?
|
| Nuclear Medicine | 1 | 2016 | 261 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2016 | 318 | 0.100 |
Why?
|
| Neointima | 1 | 2013 | 133 | 0.100 |
Why?
|
| Smad4 Protein | 1 | 2014 | 194 | 0.100 |
Why?
|
| Hand Deformities, Congenital | 1 | 2014 | 175 | 0.100 |
Why?
|
| Pyrimidines | 3 | 2022 | 3048 | 0.100 |
Why?
|
| Stomach | 1 | 2017 | 702 | 0.100 |
Why?
|
| Antigens, CD | 2 | 2019 | 4025 | 0.100 |
Why?
|
| Signal Transduction | 12 | 2016 | 23600 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1466 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2005 | 2743 | 0.100 |
Why?
|
| Adhesives | 1 | 2012 | 66 | 0.100 |
Why?
|
| Teleradiology | 1 | 2012 | 52 | 0.100 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 385 | 0.100 |
Why?
|
| Donor Selection | 1 | 2014 | 242 | 0.100 |
Why?
|
| Troponin T | 2 | 2024 | 785 | 0.100 |
Why?
|
| Military Personnel | 1 | 2021 | 1260 | 0.100 |
Why?
|
| Up-Regulation | 4 | 2009 | 4133 | 0.100 |
Why?
|
| Aneurysm, Infected | 1 | 2012 | 82 | 0.100 |
Why?
|
| Aldosterone | 2 | 2010 | 881 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2024 | 2570 | 0.100 |
Why?
|
| New Mexico | 1 | 2012 | 80 | 0.100 |
Why?
|
| Cardiology | 2 | 2016 | 1694 | 0.100 |
Why?
|
| Coronary Stenosis | 2 | 2010 | 798 | 0.100 |
Why?
|
| Acute Disease | 4 | 2016 | 7237 | 0.100 |
Why?
|
| Prognosis | 4 | 2019 | 29904 | 0.100 |
Why?
|
| Syndrome | 1 | 2018 | 3270 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8925 | 0.090 |
Why?
|
| Europe | 3 | 2019 | 3428 | 0.090 |
Why?
|
| Brain Infarction | 1 | 2013 | 285 | 0.090 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2014 | 340 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2010 | 153 | 0.090 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 18314 | 0.090 |
Why?
|
| E2F3 Transcription Factor | 2 | 2008 | 36 | 0.090 |
Why?
|
| Aortic Aneurysm | 2 | 2021 | 649 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2010 | 262 | 0.090 |
Why?
|
| Cadaver | 1 | 2015 | 1362 | 0.090 |
Why?
|
| Radiology Information Systems | 2 | 2013 | 535 | 0.090 |
Why?
|
| Myeloid Cells | 3 | 2017 | 838 | 0.090 |
Why?
|
| Isoxazoles | 1 | 2013 | 233 | 0.090 |
Why?
|
| Streptococcus anginosus | 1 | 2011 | 25 | 0.090 |
Why?
|
| Angiography | 2 | 2014 | 1589 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2004 | 2161 | 0.090 |
Why?
|
| Bronchography | 1 | 2011 | 74 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2012 | 180 | 0.090 |
Why?
|
| Fusobacterium | 1 | 2011 | 56 | 0.090 |
Why?
|
| Organ Size | 1 | 2016 | 2260 | 0.090 |
Why?
|
| Thoracic Arteries | 1 | 2010 | 40 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2158 | 0.090 |
Why?
|
| Kinetics | 5 | 2005 | 6273 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 742 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2015 | 701 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2015 | 5019 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2015 | 1414 | 0.080 |
Why?
|
| Brain Abscess | 1 | 2011 | 122 | 0.080 |
Why?
|
| Hardness | 1 | 2009 | 33 | 0.080 |
Why?
|
| Renal Insufficiency | 2 | 2014 | 810 | 0.080 |
Why?
|
| Joint Diseases | 1 | 2014 | 459 | 0.080 |
Why?
|
| Hematoma | 2 | 2005 | 765 | 0.080 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2009 | 70 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 707 | 0.080 |
Why?
|
| Comorbidity | 3 | 2020 | 10577 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 696 | 0.080 |
Why?
|
| Sarcoma | 1 | 2021 | 1801 | 0.080 |
Why?
|
| Purines | 2 | 2019 | 616 | 0.080 |
Why?
|
| Tongue Diseases | 1 | 2010 | 70 | 0.080 |
Why?
|
| Leukocytes | 1 | 2017 | 2030 | 0.080 |
Why?
|
| Carotid Stenosis | 2 | 2007 | 857 | 0.080 |
Why?
|
| Abdominal Pain | 2 | 2012 | 1069 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2022 | 1711 | 0.080 |
Why?
|
| Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
| Syndecan-1 | 1 | 2010 | 163 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2020 | 1542 | 0.080 |
Why?
|
| Oral Ulcer | 1 | 2010 | 95 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4565 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 543 | 0.080 |
Why?
|
| Pulmonary Alveoli | 2 | 2022 | 665 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2014 | 633 | 0.080 |
Why?
|
| Ultrasonography | 4 | 2014 | 5988 | 0.080 |
Why?
|
| Bronchiectasis | 1 | 2010 | 141 | 0.080 |
Why?
|
| Polyuria | 1 | 2008 | 37 | 0.080 |
Why?
|
| Temperature | 2 | 2008 | 2227 | 0.080 |
Why?
|
| False Negative Reactions | 1 | 2010 | 570 | 0.080 |
Why?
|
| Behcet Syndrome | 1 | 2009 | 86 | 0.080 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2015 | 708 | 0.080 |
Why?
|
| Viscosity | 1 | 2009 | 334 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1621 | 0.080 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 455 | 0.080 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4527 | 0.080 |
Why?
|
| Jaundice | 1 | 2009 | 94 | 0.080 |
Why?
|
| Neutrophils | 4 | 2017 | 3770 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 1 | 2002 | 3889 | 0.080 |
Why?
|
| Elastic Modulus | 1 | 2009 | 208 | 0.080 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 1496 | 0.080 |
Why?
|
| Necrosis | 2 | 2011 | 1614 | 0.080 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2009 | 153 | 0.080 |
Why?
|
| Monocytes | 3 | 2017 | 2591 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 319 | 0.070 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2007 | 24 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2010 | 255 | 0.070 |
Why?
|
| Catheterization | 1 | 2013 | 1426 | 0.070 |
Why?
|
| Brain | 7 | 2019 | 27171 | 0.070 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2007 | 51 | 0.070 |
Why?
|
| Genes, ras | 2 | 2009 | 656 | 0.070 |
Why?
|
| Shock | 1 | 2010 | 316 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3457 | 0.070 |
Why?
|
| Phorbol Esters | 2 | 2007 | 108 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3942 | 0.070 |
Why?
|
| Fibroblasts | 3 | 2024 | 4161 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 1029 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2019 | 1432 | 0.070 |
Why?
|
| Protein Splicing | 1 | 2007 | 16 | 0.070 |
Why?
|
| Chimera | 1 | 2009 | 455 | 0.070 |
Why?
|
| Solvents | 1 | 2008 | 299 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8524 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2013 | 903 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2024 | 6492 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2005 | 1748 | 0.070 |
Why?
|
| Tinnitus | 1 | 2010 | 197 | 0.070 |
Why?
|
| Binding Sites | 4 | 2014 | 6002 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2007 | 96 | 0.070 |
Why?
|
| Pulmonary Edema | 2 | 2007 | 409 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1283 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2014 | 822 | 0.070 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 1276 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2013 | 1592 | 0.070 |
Why?
|
| Coronary Thrombosis | 1 | 2010 | 440 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 241 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2012 | 1113 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2008 | 279 | 0.070 |
Why?
|
| Time | 1 | 2008 | 549 | 0.070 |
Why?
|
| Bronchi | 1 | 2011 | 847 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 938 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 1995 | 2142 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2008 | 284 | 0.070 |
Why?
|
| Embolectomy | 1 | 2007 | 130 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2019 | 3610 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2012 | 11642 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2014 | 1216 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 1 | 2010 | 275 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2009 | 389 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 3186 | 0.070 |
Why?
|
| Optic Neuritis | 1 | 2008 | 172 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1825 | 0.070 |
Why?
|
| Paresis | 1 | 2007 | 177 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2007 | 2864 | 0.060 |
Why?
|
| Jogging | 1 | 2005 | 18 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1172 | 0.060 |
Why?
|
| Hypesthesia | 1 | 2006 | 106 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 4520 | 0.060 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 988 | 0.060 |
Why?
|
| Ischemia | 1 | 2014 | 1904 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2022 | 1566 | 0.060 |
Why?
|
| Blindness | 1 | 2010 | 584 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 1423 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 666 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2007 | 344 | 0.060 |
Why?
|
| Chemokines | 5 | 2017 | 959 | 0.060 |
Why?
|
| Surface Properties | 1 | 2008 | 1152 | 0.060 |
Why?
|
| Appendicitis | 1 | 2012 | 680 | 0.060 |
Why?
|
| Sotalol | 1 | 2005 | 47 | 0.060 |
Why?
|
| Apoptosis | 6 | 2019 | 9507 | 0.060 |
Why?
|
| Transfection | 1 | 2013 | 5739 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6101 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3431 | 0.060 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2005 | 158 | 0.060 |
Why?
|
| Aggrecans | 1 | 2005 | 88 | 0.060 |
Why?
|
| Pilonidal Sinus | 1 | 2005 | 17 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2012 | 10736 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2021 | 4854 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2015 | 15803 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1695 | 0.060 |
Why?
|
| Metoprolol | 1 | 2005 | 90 | 0.060 |
Why?
|
| Proteinuria | 2 | 2005 | 606 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2012 | 1962 | 0.060 |
Why?
|
| Materials Testing | 1 | 2008 | 868 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 609 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5695 | 0.060 |
Why?
|
| Intermittent Claudication | 1 | 2007 | 305 | 0.060 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 139 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 4282 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 759 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2005 | 289 | 0.060 |
Why?
|
| RNA Interference | 1 | 2013 | 2825 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2328 | 0.060 |
Why?
|
| Paraganglioma | 1 | 2006 | 143 | 0.060 |
Why?
|
| Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
| Multigene Family | 1 | 2008 | 1081 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2007 | 596 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2012 | 938 | 0.060 |
Why?
|
| Exercise Test | 1 | 2012 | 2185 | 0.060 |
Why?
|
| Thrombophlebitis | 1 | 2005 | 289 | 0.060 |
Why?
|
| Purpura | 1 | 2005 | 116 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2009 | 811 | 0.060 |
Why?
|
| Plants | 1 | 2006 | 332 | 0.060 |
Why?
|
| Contrast Media | 5 | 2020 | 5329 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2013 | 2324 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 192 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2006 | 386 | 0.060 |
Why?
|
| Pharyngitis | 1 | 2006 | 221 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2018 | 8529 | 0.060 |
Why?
|
| Antigens | 1 | 2009 | 1437 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1814 | 0.060 |
Why?
|
| Hypotension | 2 | 2007 | 885 | 0.060 |
Why?
|
| Dimerization | 2 | 2005 | 881 | 0.060 |
Why?
|
| Membrane Proteins | 5 | 2013 | 7850 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2425 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 39233 | 0.060 |
Why?
|
| Bacteremia | 1 | 2011 | 987 | 0.060 |
Why?
|
| Time Factors | 4 | 2021 | 40100 | 0.060 |
Why?
|
| Nausea | 1 | 2006 | 679 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1494 | 0.050 |
Why?
|
| Kidney Diseases | 3 | 2013 | 2100 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2002 | 2495 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 1674 | 0.050 |
Why?
|
| Models, Animal | 3 | 2008 | 2120 | 0.050 |
Why?
|
| Unconsciousness | 1 | 2005 | 250 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1967 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2012 | 1620 | 0.050 |
Why?
|
| Plasma Exchange | 1 | 2024 | 160 | 0.050 |
Why?
|
| Cyclooxygenase 1 | 1 | 2003 | 98 | 0.050 |
Why?
|
| Diacylglycerol Kinase | 1 | 2003 | 47 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2009 | 998 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 847 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2012 | 2501 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2007 | 553 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3359 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2004 | 12128 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2023 | 54797 | 0.050 |
Why?
|
| Adolescent | 9 | 2022 | 88808 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2005 | 506 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2013 | 2030 | 0.050 |
Why?
|
| Running | 1 | 2007 | 488 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 694 | 0.050 |
Why?
|
| Dextrans | 1 | 2004 | 569 | 0.050 |
Why?
|
| Cytokines | 7 | 2016 | 7425 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 1527 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2009 | 2226 | 0.050 |
Why?
|
| Permeability | 1 | 2004 | 726 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2021 | 1966 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 873 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2004 | 296 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 213 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 319 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2003 | 275 | 0.050 |
Why?
|
| Spleen | 3 | 2013 | 2294 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2024 | 508 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2003 | 1644 | 0.050 |
Why?
|
| Young Adult | 7 | 2022 | 59857 | 0.050 |
Why?
|
| Cell Survival | 3 | 2008 | 5744 | 0.050 |
Why?
|
| Boston | 1 | 2015 | 9336 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11858 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2009 | 871 | 0.050 |
Why?
|
| Chromatography | 1 | 2001 | 187 | 0.050 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2001 | 58 | 0.050 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2008 | 1206 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2006 | 1149 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2021 | 41675 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2002 | 69 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 15882 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2012 | 2694 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2014 | 24272 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1903 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2003 | 1688 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 429 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 267 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2001 | 240 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4354 | 0.050 |
Why?
|
| Viral Load | 2 | 2021 | 3386 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 265 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2005 | 467 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2001 | 333 | 0.050 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2535 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2002 | 422 | 0.050 |
Why?
|
| Trypsin | 1 | 2002 | 487 | 0.050 |
Why?
|
| Estradiol | 1 | 2008 | 1947 | 0.050 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 9536 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2005 | 772 | 0.050 |
Why?
|
| K562 Cells | 1 | 2003 | 644 | 0.050 |
Why?
|
| Placenta | 1 | 2010 | 1726 | 0.050 |
Why?
|
| Proteomics | 2 | 2024 | 3907 | 0.050 |
Why?
|
| Lymphoma | 1 | 2010 | 1897 | 0.050 |
Why?
|
| Explosions | 1 | 2021 | 106 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 1724 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 828 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2024 | 2115 | 0.050 |
Why?
|
| DNA | 2 | 2014 | 7192 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 1276 | 0.050 |
Why?
|
| Hand | 1 | 2006 | 909 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 6 | 2010 | 6215 | 0.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 415 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 596 | 0.040 |
Why?
|
| Chickens | 1 | 2003 | 842 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9743 | 0.040 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 943 | 0.040 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2022 | 307 | 0.040 |
Why?
|
| Vitamin A | 1 | 2003 | 611 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2016 | 6595 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 540 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2024 | 2574 | 0.040 |
Why?
|
| Autoantigens | 1 | 2024 | 886 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2003 | 777 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2003 | 419 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8724 | 0.040 |
Why?
|
| CHO Cells | 1 | 2003 | 1373 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2001 | 577 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 505 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2009 | 1222 | 0.040 |
Why?
|
| Life Style | 1 | 2012 | 3926 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2002 | 1061 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2006 | 771 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2005 | 855 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4463 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2002 | 731 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2003 | 5125 | 0.040 |
Why?
|
| Ethanol | 1 | 2006 | 1326 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 247 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 693 | 0.040 |
Why?
|
| Mitochondrial Diseases | 1 | 2003 | 344 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2010 | 2158 | 0.040 |
Why?
|
| Microscopy | 1 | 2024 | 900 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 292 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 588 | 0.040 |
Why?
|
| Cricetinae | 1 | 2003 | 2413 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1167 | 0.040 |
Why?
|
| Receptors, Chemokine | 4 | 2003 | 651 | 0.040 |
Why?
|
| Cysteine | 1 | 2004 | 898 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 308 | 0.040 |
Why?
|
| Peroxidase | 2 | 2014 | 610 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2014 | 4859 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3684 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 3529 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 2007 | 903 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 1211 | 0.040 |
Why?
|
| RNA | 2 | 2007 | 2715 | 0.040 |
Why?
|
| Pedigree | 1 | 2006 | 4535 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 4627 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 1789 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 21072 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2006 | 1806 | 0.040 |
Why?
|
| Hypertension | 3 | 2007 | 8609 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3436 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2476 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2012 | 812 | 0.040 |
Why?
|
| Wound Healing | 1 | 2009 | 2794 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5755 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 329 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2021 | 533 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2006 | 918 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 640 | 0.040 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2017 | 22 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1936 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2005 | 1087 | 0.040 |
Why?
|
| Protein Folding | 1 | 2001 | 868 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2001 | 681 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 735 | 0.040 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2004 | 1721 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5388 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 2419 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 567 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2001 | 1441 | 0.040 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2016 | 25 | 0.030 |
Why?
|
| Anemia | 1 | 2007 | 1514 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1870 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 14644 | 0.030 |
Why?
|
| Colon | 1 | 2005 | 1797 | 0.030 |
Why?
|
| Pericardial Effusion | 2 | 2010 | 245 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3584 | 0.030 |
Why?
|
| Graft Survival | 3 | 2002 | 3904 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 36424 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 2242 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2003 | 3070 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 2 | 2010 | 250 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2013 | 3947 | 0.030 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 1459 | 0.030 |
Why?
|
| Indoles | 1 | 2005 | 1832 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1406 | 0.030 |
Why?
|
| Plasmids | 1 | 2001 | 2266 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1927 | 0.030 |
Why?
|
| Antibodies | 1 | 2004 | 2415 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1889 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 807 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2016 | 109 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 1803 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 331 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2016 | 85 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2006 | 4408 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 834 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 4649 | 0.030 |
Why?
|
| Point Mutation | 1 | 2021 | 1591 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 3733 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5939 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2009 | 6254 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 18076 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2016 | 380 | 0.030 |
Why?
|
| Virginia | 1 | 2015 | 115 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2019 | 576 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2013 | 1150 | 0.030 |
Why?
|
| Protein Binding | 2 | 2005 | 9302 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1995 | 291 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2008 | 1897 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 2016 | 175 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 787 | 0.030 |
Why?
|
| Tunica Media | 1 | 2015 | 107 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 271 | 0.030 |
Why?
|
| Feces | 1 | 2022 | 1503 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 1610 | 0.030 |
Why?
|
| Gadolinium | 1 | 2020 | 966 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 1362 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2022 | 42509 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2009 | 1886 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 1001 | 0.030 |
Why?
|
| Nasal Septum | 1 | 2016 | 131 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2007 | 3464 | 0.030 |
Why?
|
| Neurons | 3 | 2022 | 9520 | 0.030 |
Why?
|
| Movement | 1 | 2021 | 1461 | 0.030 |
Why?
|
| Bundle-Branch Block | 1 | 2016 | 280 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2014 | 1428 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2005 | 4209 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2016 | 357 | 0.030 |
Why?
|
| Reference Values | 1 | 2021 | 4909 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 295 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 1727 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 527 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13634 | 0.030 |
Why?
|
| Base Sequence | 3 | 2017 | 12405 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2014 | 198 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 4047 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2001 | 3604 | 0.030 |
Why?
|
| Rheumatology | 1 | 2019 | 620 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1996 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2024 | 2747 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2135 | 0.030 |
Why?
|
| Heterozygote | 2 | 2014 | 2796 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2012 | 52 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 224 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2005 | 1912 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2013 | 124 | 0.030 |
Why?
|
| Piperazines | 1 | 2003 | 2547 | 0.030 |
Why?
|
| Catechols | 1 | 2012 | 63 | 0.030 |
Why?
|
| Vertebral Artery | 1 | 2014 | 185 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2003 | 1244 | 0.030 |
Why?
|
| Protein Transport | 3 | 2003 | 1939 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 1093 | 0.030 |
Why?
|
| Renal Artery | 1 | 2014 | 355 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2012 | 98 | 0.030 |
Why?
|
| Logistic Models | 1 | 2007 | 13272 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 610 | 0.030 |
Why?
|
| Back Pain | 1 | 2016 | 546 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 2043 | 0.020 |
Why?
|
| Iohexol | 1 | 2013 | 205 | 0.020 |
Why?
|
| Regeneration | 1 | 2021 | 1516 | 0.020 |
Why?
|
| Sheep | 1 | 2015 | 1445 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Oxygen | 1 | 2003 | 4247 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2008 | 3787 | 0.020 |
Why?
|
| Skin Neoplasms | 2 | 2009 | 5836 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12802 | 0.020 |
Why?
|
| Peptides | 1 | 2004 | 4338 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2445 | 0.020 |
Why?
|
| Injections | 1 | 2015 | 839 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2016 | 586 | 0.020 |
Why?
|
| Limb Salvage | 1 | 2014 | 488 | 0.020 |
Why?
|
| Gels | 1 | 2012 | 420 | 0.020 |
Why?
|
| I-kappa B Proteins | 2 | 2002 | 210 | 0.020 |
Why?
|
| Appendix | 1 | 2012 | 110 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8613 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2175 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3605 | 0.020 |
Why?
|
| Pregnancy | 2 | 2010 | 30227 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 1029 | 0.020 |
Why?
|
| Abdominal Abscess | 1 | 2012 | 152 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1077 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3249 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2016 | 683 | 0.020 |
Why?
|
| Pain | 1 | 2006 | 5085 | 0.020 |
Why?
|
| Germinal Center | 1 | 2013 | 379 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2009 | 2677 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26280 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 18382 | 0.020 |
Why?
|
| Smoking | 1 | 2007 | 9076 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1105 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3679 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 4910 | 0.020 |
Why?
|
| Prescriptions | 1 | 2012 | 388 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 3801 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6208 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 582 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2017 | 10089 | 0.020 |
Why?
|
| Sex Factors | 1 | 2004 | 10611 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3200 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12821 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 9446 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2897 | 0.020 |
Why?
|
| Posture | 1 | 2014 | 955 | 0.020 |
Why?
|
| Isoantigens | 2 | 2001 | 562 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2269 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1247 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1520 | 0.020 |
Why?
|
| Thrombin | 1 | 1991 | 600 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2011 | 298 | 0.020 |
Why?
|
| Conscious Sedation | 1 | 2013 | 534 | 0.020 |
Why?
|
| Cell Line | 1 | 2003 | 15545 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2009 | 772 | 0.020 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2010 | 167 | 0.020 |
Why?
|
| Pathology, Molecular | 1 | 2011 | 329 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2865 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 538 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 115 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 2 | 2007 | 1490 | 0.020 |
Why?
|
| United States | 2 | 2019 | 72916 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2879 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2007 | 49 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 683 | 0.020 |
Why?
|
| Prevalence | 2 | 2015 | 15820 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3051 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2007 | 107 | 0.020 |
Why?
|
| Arteries | 1 | 2012 | 1121 | 0.020 |
Why?
|
| Atherectomy | 1 | 2007 | 41 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1670 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2008 | 224 | 0.020 |
Why?
|
| Neoplasms, Experimental | 2 | 2003 | 1227 | 0.020 |
Why?
|
| Fear | 1 | 2016 | 1496 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 682 | 0.020 |
Why?
|
| Violence | 1 | 2014 | 931 | 0.020 |
Why?
|
| Phenotype | 3 | 2017 | 16712 | 0.020 |
Why?
|
| HIV-1 | 1 | 2005 | 6948 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2009 | 387 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2007 | 55 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2009 | 309 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2001 | 5914 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 3606 | 0.020 |
Why?
|
| Karyotyping | 1 | 2009 | 1175 | 0.020 |
Why?
|
| Receptor, erbB-2 | 2 | 2009 | 2593 | 0.020 |
Why?
|
| Family | 1 | 2017 | 3208 | 0.020 |
Why?
|
| Esterification | 1 | 2006 | 38 | 0.020 |
Why?
|
| Superoxides | 1 | 2007 | 382 | 0.020 |
Why?
|
| Motor Activity | 1 | 2016 | 2711 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 633 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2005 | 5182 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2002 | 978 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 612 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1605 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 1014 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1287 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 1023 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2012 | 922 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 514 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2007 | 455 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 678 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2007 | 4188 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2010 | 873 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 996 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5924 | 0.020 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2006 | 128 | 0.020 |
Why?
|
| Endocarditis | 1 | 2009 | 348 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1404 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2008 | 477 | 0.020 |
Why?
|
| Child | 3 | 2022 | 80567 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2008 | 743 | 0.010 |
Why?
|
| Ubiquitination | 1 | 2009 | 1000 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2011 | 2200 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 17070 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2825 | 0.010 |
Why?
|
| Alloys | 1 | 2005 | 109 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2014 | 2389 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3499 | 0.010 |
Why?
|
| Virus Assembly | 1 | 2005 | 140 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9524 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 822 | 0.010 |
Why?
|
| Polyurethanes | 1 | 2005 | 110 | 0.010 |
Why?
|
| Filtration | 1 | 2005 | 227 | 0.010 |
Why?
|
| Keratin-10 | 1 | 2003 | 8 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2611 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6506 | 0.010 |
Why?
|
| Canada | 1 | 2009 | 2120 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2005 | 423 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2014 | 2646 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 102 | 0.010 |
Why?
|
| Hindlimb | 1 | 2006 | 512 | 0.010 |
Why?
|
| Gene Expression | 2 | 2008 | 7581 | 0.010 |
Why?
|
| ras-GRF1 | 1 | 2003 | 26 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 102 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 2002 | 4860 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 1318 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 4163 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2002 | 71 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2009 | 1894 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2003 | 314 | 0.010 |
Why?
|
| Self Tolerance | 1 | 2003 | 119 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 812 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4779 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 2510 | 0.010 |
Why?
|
| Motor Skills | 1 | 2006 | 519 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2002 | 103 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2003 | 822 | 0.010 |
Why?
|
| Retrograde Degeneration | 1 | 2002 | 7 | 0.010 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 550 | 0.010 |
Why?
|
| Axotomy | 1 | 2002 | 71 | 0.010 |
Why?
|
| Keratins | 1 | 2003 | 496 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2001 | 139 | 0.010 |
Why?
|
| Polycythemia Vera | 1 | 2003 | 160 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 501 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 655 | 0.010 |
Why?
|
| Fibrin | 1 | 2005 | 513 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2007 | 1517 | 0.010 |
Why?
|
| Vertebrates | 1 | 2003 | 227 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2009 | 2197 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 2002 | 182 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 2001 | 91 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 412 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3853 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 1961 | 0.010 |
Why?
|
| Genotype | 1 | 2016 | 13029 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 269 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 738 | 0.010 |
Why?
|
| Anxiety | 1 | 2016 | 4671 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 265 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2210 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 538 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 2227 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 1134 | 0.010 |
Why?
|
| Transplantation | 1 | 2002 | 222 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 257 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1242 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 2729 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2454 | 0.010 |
Why?
|
| Cathepsins | 1 | 2001 | 242 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1376 | 0.010 |
Why?
|
| Epidermis | 1 | 2003 | 536 | 0.010 |
Why?
|
| Carotenoids | 1 | 2003 | 620 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 8717 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 2056 | 0.010 |
Why?
|
| Fetus | 1 | 2008 | 1878 | 0.010 |
Why?
|
| Aging | 2 | 2014 | 8722 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2002 | 726 | 0.010 |
Why?
|
| Fibrosis | 1 | 2007 | 2073 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2878 | 0.010 |
Why?
|
| Sodium, Dietary | 1 | 2003 | 426 | 0.010 |
Why?
|
| Spironolactone | 1 | 2003 | 415 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 1159 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 3405 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2001 | 1168 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2002 | 335 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 4730 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3488 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 1769 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8037 | 0.010 |
Why?
|
| Stem Cells | 1 | 2012 | 3537 | 0.010 |
Why?
|
| Genes | 1 | 2003 | 1824 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2012 | 3617 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2001 | 392 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 4277 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2003 | 861 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 657 | 0.010 |
Why?
|
| Algorithms | 2 | 2014 | 14065 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1205 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 8062 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2007 | 1885 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4249 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1242 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2001 | 616 | 0.010 |
Why?
|
| Neocortex | 1 | 2002 | 414 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 1346 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1376 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6544 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 2877 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2898 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2003 | 1377 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 1677 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 2927 | 0.010 |
Why?
|
| Curriculum | 1 | 2010 | 3784 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 1755 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 5986 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 2901 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 7599 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 2838 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2006 | 2857 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21509 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4616 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 5383 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 1888 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 2667 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3635 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2006 | 2787 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 3227 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2003 | 3077 | 0.010 |
Why?
|
| Operon | 1 | 1991 | 371 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4342 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2003 | 3002 | 0.010 |
Why?
|
| Genome, Human | 1 | 2003 | 4442 | 0.010 |
Why?
|
| Catalysis | 1 | 1991 | 767 | 0.010 |
Why?
|
| Seizures | 1 | 2003 | 2997 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 2223 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 11906 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1991 | 3399 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1991 | 5784 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1991 | 3831 | 0.000 |
Why?
|